PROCEPT BioRobotics Corporation Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 3 | -$0.57 | -$0.55 | -$0.56 |
Q2 2024 | 2 | -$0.53 | -$0.51 | -$0.52 |
Q3 2024 | 2 | -$0.50 | -$0.48 | -$0.49 |
Q4 2024 | 6 | -$0.40 | -$0.29 | -$0.34 |
Q1 2025 | 3 | -$0.39 | -$0.35 | -$0.38 |
Q2 2025 | 2 | -$0.38 | -$0.36 | -$0.37 |
Q3 2025 | 2 | -$0.35 | -$0.34 | -$0.34 |
Q4 2025 | 2 | -$0.28 | -$0.27 | -$0.28 |
Q1 2026 | 1 | -$0.19 | -$0.19 | -$0.19 |
Q2 2026 | 1 | -$0.20 | -$0.20 | -$0.20 |
Q3 2026 | 1 | -$0.16 | -$0.16 | -$0.16 |
Q4 2026 | 1 | -$0.09 | -$0.09 | -$0.09 |
PROCEPT BioRobotics Corporation Earnings Date And Information
PROCEPT BioRobotics Corporation last posted its earnings results on Monday, October 28th, 2024. The company reported $-0.4 earnings per share for the quarter, topping analysts' consensus estimates of $-0.48 by $0.08. The company had revenue of 58.37 M for the quarter and had revenue of 136.19 M for the year. PROCEPT BioRobotics Corporation has generated $-2 earnings per share over the last year ($-2.24 diluted earnings per share) and currently has a price-to-earnings ratio of -47.29. PROCEPT BioRobotics Corporation has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
PROCEPT BioRobotics Corporation Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
10/28/2024 | Q3 2024 | -$0.48 | -$0.40 | 0.08 | $53.30 M | $58.37 M |
08/02/2024 | Q2 2024 | -$0.50 | $50.10 M | $53.35 M | ||
06/27/2024 | Q1 2024 | -$0.51 | $44.54 M | |||
02/28/2024 | Q4 2023 | -$0.54 | $43.58 M | |||
11/02/2023 | Q3 2023 | -$0.51 | $34.09 M | $35.10 M | ||
07/28/2023 | Q2 2023 | -$0.56 | $30.31 M | $33.10 M | ||
05/04/2023 | Q1 2023 | -$0.61 | $24.40 M | |||
02/28/2023 | Q4 2022 | -$0.53 | -$0.70 | -0.17 | $23.78 M | |
11/04/2022 | Q3 2022 | -$0.52 | $17.04 M | $20.35 M | ||
08/05/2022 | Q2 2022 | -$0.46 | $14.41 M | $16.69 M | ||
05/06/2022 | Q1 2022 | -$0.43 | $14.20 M | |||
03/22/2022 | Q4 2021 | -$0.42 | $10.14 M | |||
11/05/2021 | Q3 2021 | -$1.22 | $7.11 M | $8.67 M | ||
06/30/2021 | Q2 2021 | -$0.35 | $8.48 M | |||
03/31/2021 | Q1 2021 | -$0.36 | $7.19 M | |||
12/30/2020 | Q4 2020 | -$0.43 | $3.22 M | |||
09/29/2020 | Q3 2020 | -$0.34 | $2.11 M | |||
06/29/2020 | Q2 2020 | -$4.56 | $1.19 M | |||
03/30/2020 | Q1 2020 | -$4.56 | $1.19 M |
PROCEPT BioRobotics Corporation Earnings: Frequently Asked Questions
-
When is PROCEPT BioRobotics Corporation's earnings date?
PROCEPT BioRobotics Corporation has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
-
Did PROCEPT BioRobotics Corporation beat their earnings estimates last quarter?
In the previous quarter, PROCEPT BioRobotics Corporation (:PRCT) reported $-0.4 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.48 by $0.08.
-
How can I listen to PROCEPT BioRobotics Corporation's earnings conference call?
The conference call for PROCEPT BioRobotics Corporation's latest earnings report can be listened to online.
-
How can I read PROCEPT BioRobotics Corporation's conference call transcript?
The conference call transcript for PROCEPT BioRobotics Corporation's latest earnings report can be read online.
-
How much revenue does PROCEPT BioRobotics Corporation generate each year?
PROCEPT BioRobotics Corporation (:PRCT) has a recorded annual revenue of $136.19 M.
-
How much profit does PROCEPT BioRobotics Corporation generate each year?
PROCEPT BioRobotics Corporation (:PRCT) has a recorded net income of $136.19 M. PROCEPT BioRobotics Corporation has generated $-2.24 earnings per share over the last four quarters.
-
What is PROCEPT BioRobotics Corporation's price-to-earnings ratio?
PROCEPT BioRobotics Corporation (:PRCT) has a price-to-earnings ratio of -47.29 and price/earnings-to-growth ratio is -8.86.